Other Pulmonary Disorders Flashcards

1
Q

asthma mgmt/monitoring

A
  • methacholine challenge if unsure if asthma (dec > 20%)
  • peak flow qd at home (will change prior to sx onset)
  • assess tx via night awakenings, SABA use, ER/UC visits
  • step up med if nighttime 2+ q month
  • office spirometry preferred to peak flow if avail
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

asthma pcp tx for adult exacerbation

A
  • peak > 70% predicted: SABA x 3, d/c home
  • peak 40-69%: SABA x 3 + PO steroid if no improvement
  • peak < 40%: ER
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

asthma pcp tx for peds exacerbation

A
  • use pulmonary index score (RR, wheeze, insp:exp)
  • mild: SABA neb x 3 w/ PO steroids s/p 1st dose if no improvement
  • mod: O2 prn, SABA + ipratropium neb x 3 w/ PO steroids s/p 1st dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

step of asthma tx

A
  • SABA prn
  • low-dose ICS + SABA prn
  • med-dose ICS OR (low-dose ICS + LABA) + SABA prn
  • med-dose ICS + LABA
  • high-dose ICS + LABA AND (allergy tx)
  • high-dose ICS + LABA + PO steroid AND (allergy tx)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cannot give LABA w/o ____ in asthma

A

ICS (increased mort)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SABA’s

A
  • albuterol, levalbuterol

- if more than 1 cannister q month OR 2+ x/wk : step up tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

anticholinergics

A
  • ipratropium (short), tiotropium (long)

- alt to SABA or adjunct for severe exacerbation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

systemic corticosteroids

A
  • prednisone

- x 3-10 days for exacerbation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

inhaled corticosteroids

A
  • budesonide, beclomethasone, fluticasone, mometasone

- use a spacer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

LABA’s

A
  • salmeterol, fomoterol, indacaterol
  • use for short duration (control sx)
  • use combo inhlrs (need ICS)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

leukotriene modifiers

A
  • montelukast, zafirlukast, zileuton

- good for exercise-induced asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

mast cell stabilizers

A
  • cromolyn
  • good for seasonal asthma, exercise-indused bronchospasm
  • takes 2 wks for therapeutic response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

theophylline

A
  • bronchodilator
  • adjunct to ICS for mgmt of nighttime sx
  • req serum monitoring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

omalizumab

A
  • anti-inflammatory

- for sev allergic asthma in pts w/ freq exacerbations & already on high steroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

asthma exacerbation tx options

A
  • duoneb (albuterol + ipratropium) q 20 min x 3 (MDI/inhlr just as effective as neb)
  • PO/IV steroids if poor resp
  • supp O2 prn
  • NO ICS!
  • MgS for refractory cases
  • mechanical vent if peak stays < 25%
  • admit if not responding in 4-6 hrs of tx
  • nonstandard tx: montelukast, helium, furosemide, ketamine, macrolides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

asthma classifications

A
  • intermittent: < 2x/wk, < 2/mos nights, < 2 SABA d/wk
  • mild p: inbetween
  • mod p: daily sx, > 1x/wk nights, SABA daily
  • sev p: sx throughout day, q night, SABA muliple x/day
17
Q

CF

A
  • autosomal recessive, white
  • mucus obstruction, inflam, inf, fibrosis
  • affects pancreas & vas deferens
18
Q

CF s/s

A
  • recurrent pulm inf w/ atypical bact (s aureus in infancy, psudomonas in adult)
  • FTT
  • meconium ileus
  • pancreatitis
  • infertility
  • delayed puberty
19
Q

CF acute exacerbations

A
  • bronchial rather than PNA
  • increased sputum/cough/color change
  • decreased exercise tolerance
  • poor appetite
20
Q

CF wu

A
  • newborn screens (only detect sev dx)
  • DNA (buccal)
  • sweat chloride is confirmatory
21
Q

CF mgmt

A
  • dietary support (higher BMI assoc w/ better lung fxn)
  • promote mucus clearance (chest PT, veste, CPAP, albut)
  • inf control (cyclic abx use, x 2-3 wk s/p exacerbation)
  • freq office appts w/ PFTs, sputum cx, DEXA, PT/PTT, LFT, albumin, vaccines
22
Q

CF prog

A
  • median age of survival is 38
  • lung fx declines ~ 2% q yr (accelerates q exacerbation)
  • pts unable to return to prev baseline s/p q exacerbation)